Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle

Clinical trial NCT02578771 · COMPLETED

Trial details

NCT number: NCT02578771
Sponsor: Zurex Pharma, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Surgical Site Infection

Start date: 2015-10-01
Primary completion: 2016-01-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.